<DOC>
	<DOCNO>NCT00225654</DOCNO>
	<brief_summary>ELUTES European multicenter , randomize , control , triple-blinded study design evaluate ability Paclitaxel Eluting V-Flex Plus coronary stent reduce restenosis coronary artery .</brief_summary>
	<brief_title>The ELUTES Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patient must eligible undergo plan treatment single de novo lesion native coronary artery . Patient must acceptable candidate coronary artery bypass surgery . Patient legal guardian must sign informed consent . Patient agree return one month office visit ass cardiovascular status 6 month office visit ass cardiovascular status diagnostic angiogram . Patient must less 18 year old . Patient history bleed diathesis coagulopathy refuse blood transfusion . Patient simultaneously participate another investigative interventional cardiovascular device drug study . Patient known hypersensitivity contraindication aspirin , clopidogrel , stainless steel , sensitivity contrast dye . Women child bear potential . Patient medical condition may cause noncompliance protocol , confound result , associate limited life expectancy . Patient diagnose myocardial infarction within 72 hour prior procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>coronary artery</keyword>
	<keyword>stent</keyword>
	<keyword>drug elute</keyword>
	<keyword>patency</keyword>
	<keyword>restenosis</keyword>
</DOC>